Skip to main content

Table 1 Baseline characteristics

From: Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial

 

Placebo (n = 191)

Metformin (n = 194)

Sex (female)

95 (50)

113 (58)

Age

59 (11)

64 (10)

Currently smoking (yes)

59 (31)

37 (19)

Body mass index (kg/m2)

29.8 (4.8)

29.8 (5.1)

Diabetes duration (years)

12.2 (7.9)

14.2 (8.7)

Cardiovascular history score

0.9 (1.3)

1.2 (1.4)

Systolic blood pressure (mmHg)

160 (24.8)

160 (24.1)

Diastolic blood pressure (mmHg)

85.7 (11.1)

85.4 (11.9)

Blood pressure lowering drugs (yes)

74 (39)

91 (47)

Lipid lowering drugs (yes)

31 (16)

32 (17)

Cardiac Troponin I at baseline

3.0 [2.0, 5.0]

3.6 [2.3, 5.5]

Cardiac Troponin T at baseline

10.0 [6.7, 14.1]

10.2 [7.6, 14.2]

Plasma HbA1c (%, mmol/mol)

7.9 (1.2)

7.9 (1.2)

LDL cholesterol (mmol/l)

3.4 (1.0)

3.6(1.1)

Total cholesterol (mmol/l)

5.5 (1.2)

5.6 (1.3)

  1. Continuous values are presented as mean (standard deviation) or median [interquartile range], as appropriate. Categorical data are presented as absolute numbers (%). Cardiovascular history score is a sum score of cardiovascular events with a range of 0–8